Ryan Bleeks serves as Chief Executive Officer of Meibum Scientific, where he is responsible for leading the commercialization and growth of the company’s flagship technologies, BlephEx® and OptiVize®, and translating Meibum’s scientific foundation into scalable, clinic-ready solutions.
Mr. Bleeks brings more than two decades of leadership experience across ophthalmic pharmaceuticals, medical devices, and commercial operations. He previously served as Chief Executive Officer of Visiox Pharmaceuticals, where he led the company through a successful sale to a public acquirer in 2023, overseeing strategic positioning, transaction execution, and transition planning.
He has significant experience with mergers and acquisitions in the ophthalmic sector, including operational integration and post-transaction execution. Earlier in his career, Mr. Bleeks built and led large national eyecare sales organizations exceeding 130 professionals and has been directly involved in the launch and scaling of more than ten ophthalmic products.
His leadership focus is disciplined execution, building high-performance teams, and scaling platform-based solutions that create durable value for patients, clinicians, and stakeholders.